| DB ID | MyCo_4094 |
| Title | Monocyte human leukocyte antigen-DR but not β-D-glucan may help early diagnosing invasive Candida infection in critically ill patients |
| Year | 2021 |
| PMID | 34417900 |
| Fungal Diseases involved | Invasive candidiasis |
| Associated Medical Condition | Critically ill patients |
| Genus | Candida |
| Species | parapsilosis |
| Organism | Candida parapsilosis |
| Ethical Statement | The study was approved by the ethic committee (Comité de Protection des Personnes Sud-Mediterranée III, 2014-A00500-47) and followed the STARD guidelines |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | mHLA-DR < 5000 Ab/c |
| Biomarker Full Name | Monocyte human leukocyte antigen-DR < 5000 Ab/c |
| Biomarker Type | Diagnostic |
| Biomolecule | Antigen |
| Geographical Location | France |
| Cohort | Fifty patients were included in the study. |
| Cohort No. | 50 |
| Age Group | 60.5–71.3 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | Immunological assay |
| ELISA kits | None |
| Assay Data | FDA- Fungitell®, Cape Cod International, Inc.; Falmounth, MA, USA |
| Validation Techniques used | Immunological assay |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
